Gregory S. Day

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease

Richard F. Betzel, B. Adeyemo, E. McDade, 2023, bioRxiv.

Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease

J. Chhatwal, E. McDade, R. Perrin, 2023, Molecular neurodegeneration.

Clinicoradiological and neuropathological evaluation of primary progressive aphasia

Rene L. Utianski, J. Graff‐Radford, M. Murray, 2024, Journal of neurology, neurosurgery, and psychiatry.

Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia

Brian A. Gordon, Laura M. Marple, J. Morris, 2020, NeuroImage: Clinical.

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

Marzia A. Scelsi, J. Chhatwal, A. Santacruz, 2024, JAMA neurology.

Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer’s disease dementia with high accuracy in an African American cohort

Krishna R. Kalari, M. Carrasquillo, N. Graff-Radford, 2024, bioRxiv.

Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease

J. Graff‐Radford, T. Ferman, S. Przybelski, 2024, JAMA neurology.

Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans

T. Ferman, N. Graff-Radford, E. Craver, 2023, Annals of neurology.

Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature

Christian Lachner, Gregory S. Day, Stacey L. Clardy, 2024, Journal of Neuroimmunology.